Innovative & Generic Drugs Markets in Russia, Ukraine & Kazakhstan Analysed in New PMR Research Report Available at MarketPublishers.com
16 Jul 2012 • by Natalie Aster
LONDON – Among the CIS countries, Russia, Ukraine and Kazakhstan are considered to be the largest and most promising in terms of growth markets for the innovative pharmaceuticals and generic drugs. The regulatory changes within these countries have affected the way companies conduct business and thus they have to chose solutions to adapt their business models to the ever changing marketplace.
New report "Generic and Innovative Drugs Market in CIS Countries 2012. Russia, Ukraine and Kazakhstan" elaborated by PMR has been recently published by Market Publishers Ltd.
Generic and Innovative Drugs Market in CIS Countries 2012. Russia, Ukraine and Kazakhstan
Published: June, 2012
Price: US$ 2.800,00
The report provides complete coverage of current conditions in Russia, Ukraine and Kazakhstan in the field of innovative and generic drugs. It offers analysis of the complex legal environments in each country, with detailed accounts of the effects of recent and pending legislative activity on market development.
It provides extensive coverage of pricing and reimbursement regulations for each of the covered countries, including VAT rates and mark-ups. The report also covers market leaders, supplying details on the largest producers in each country and for the overall CIS market. Forecasts through 2014 offer a deep view at the future of these markets.
More new market research reports by the publisher can be found at PMR page.